Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel|DRUG: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust
Collaborators: University of Sheffield